PharmX Technologies Limited (ASX:PHX)

PharmX Technologies Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	4.48	13.14	12.81	5.76	6.48	2.32
Cash & Short-Term Investments	4.48	13.14	12.81	5.76	6.48	2.32
Cash Growth	-63.97%	2.58%	122.36%	-11.10%	178.86%	-0.43%
Accounts Receivable	0.88	0.98	0.91	1.03	0.85	0.2
Other Receivables	0.07	2.18	1.7	1.61	1.55	5.32
Receivables	0.95	3.15	2.61	2.63	2.4	5.53
Inventory	-	-	-	0.04	0.03	0.06
Prepaid Expenses	-	-	-	-	-	0.11
Other Current Assets	0.24	0.08	7.18	0.15	1.51	1.82
Total Current Assets	5.67	16.37	22.59	8.59	10.42	9.84
Property, Plant & Equipment	0.2	0.24	0.05	0.6	0.79	1.23
Long-Term Investments	-	-	-	-	-	2.69
Goodwill	2.12	2.12	2.12	2.12	2.12	-
Other Intangible Assets	9.78	10.82	11.24	18.61	17.17	4.67
Long-Term Deferred Tax Assets	0.12	0.22	0.53	0.71	0.8	0.55
Other Long-Term Assets	0.09	0.09	-	0.15	0.05	0.2
Total Assets	17.97	29.86	36.52	30.77	31.35	19.18
Accounts Payable	0.81	0.57	0.67	0.84	0.4	0.36
Accrued Expenses	-	0.15	0.13	0.88	0.91	1.2
Current Portion of Leases	0.11	0.11	0.03	0.3	0.28	0.42
Current Unearned Revenue	0.06	0.01	9.46	1.4	0.15	0.23
Other Current Liabilities	0.08	11.12	2	1.69	4.65	3.27
Total Current Liabilities	1.06	11.95	12.29	5.11	6.39	5.48
Long-Term Leases	0.08	0.13	-	0.02	0.04	0.31
Long-Term Deferred Tax Liabilities	0.62	0.87	1.01	1.02	1.14	-
Other Long-Term Liabilities	-	0.89	0.99	1.31	0.74	0.01
Total Liabilities	1.82	13.89	14.31	7.57	8.42	5.98
Common Stock	93.97	93.97	98.41	98.37	98.37	89.72
Retained Earnings	-77.87	-78.02	-76.25	-75.2	-75.45	-76.55
Comprehensive Income & Other	0.05	0.02	0.06	0.04	0.02	0.02
Shareholders' Equity	16.15	15.97	22.21	23.2	22.93	13.2
Total Liabilities & Equity	17.97	29.86	36.52	30.77	31.35	19.18
Total Debt	0.19	0.24	0.03	0.33	0.32	0.73
Net Cash (Debt)	4.29	12.9	12.77	5.43	6.16	1.59
Net Cash Growth	-64.66%	0.95%	135.12%	-11.76%	287.23%	-31.85%
Net Cash Per Share	0.01	0.02	0.02	0.01	0.01	0.00
Filing Date Shares Outstanding	598.51	598.51	597.38	596.76	596.76	402.57
Total Common Shares Outstanding	598.51	598.51	597.38	596.76	596.76	402.57
Working Capital	4.61	4.42	10.3	3.47	4.03	4.36
Book Value Per Share	0.03	0.03	0.04	0.04	0.04	0.03
Tangible Book Value	4.26	3.04	8.85	2.48	3.65	8.52
Tangible Book Value Per Share	0.01	0.01	0.01	0.00	0.01	0.02
Machinery	-	0.08	0.18	2.52	2.6	2.42
Leasehold Improvements	-	-	0.09	0.09	0.09	0.09

Source: S&P Global Market Intelligence. Standard template. Financial Sources.